Compare 10X Genomics Inc (TXG) vs United States Oil ETF (USO) Price & Performance

10x Genomics (TXG) trades at $76.10, down 5.65% on the day, as technical indicators signal bearish momentum with the stock below key resistance levels. The company shows improving fundamentals with three consecutive quarterly earnings beats and positive operating cash flow of $136M in 2025, though it remains unprofitable with a -12.18% net margin. Recent developments include the launch of Atera spatial biology platform shipments and a patent victory against Parse Biosciences.

TXG presents a mixed investment case with strong product innovation and improving financial trends offset by high valuation metrics and persistent losses. The stock's risk/reward appears balanced near analyst consensus targets, requiring successful execution on Atera commercialization and path to profitability to justify current multiples.

USO trades at $143.91, down 0.7% amid mixed oil market signals. Technical indicators show neutral sentiment with bearish moving averages, while support levels cluster around $140-142. Recent news highlights Middle East tensions and OPEC+ production decisions creating supply uncertainty. The stock faces headwinds from coordinated G-7 reserve releases but benefits from geopolitical risk premiums.

Outlook remains balanced with technical support providing downside protection while geopolitical risks and supply dynamics drive volatility. Investment opportunity exists for traders capitalizing on oil price swings, though fundamental data limitations require careful risk management given the commodity-sensitive nature of this energy-focused security.